VECRX
Price
$22.22
Change
-$0.01 (-0.04%)
Updated
Sep 3 closing price
Net Assets
136.09M
VIVIX
Price
$70.90
Change
-$0.26 (-0.37%)
Updated
Sep 3 closing price
Net Assets
195.81B
Interact to see
Advertisement

VECRX vs VIVIX

Header iconVECRX vs VIVIX Comparison
Open Charts VECRX vs VIVIXBanner chart's image
Virtus KAR Equity Income R6
Price$22.22
Change-$0.01 (-0.04%)
VolumeN/A
Net Assets136.09M
Vanguard Value Index I
Price$70.90
Change-$0.26 (-0.37%)
VolumeN/A
Net Assets195.81B
VECRX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VECRX vs. VIVIX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VECRX is a Hold and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 196B vs. VECRX (136M). VECRX pays higher dividends than VIVIX: VECRX (2.80) vs VIVIX (2.11). VECRX was incepted earlier than VIVIX: VECRX (8 years) vs VIVIX (27 years). VECRX (1.04) is less costly to investors than VIVIX (0.04). VECRX is a more actively managed with annual turnover of: 17.00 vs. VIVIX (9.00). VECRX has a lower initial minimum investment than VIVIX: VECRX (2500000) vs VIVIX (5000000). VECRX annual gain was more profitable for investors over the last year : 9.86 vs. VIVIX (6.80). VIVIX return over 5 years is better than : 70.09 vs. VECRX (8.21).
VECRXVIVIXVECRX / VIVIX
Total Expense Ratio0.780.041,950%
Annual Report Gross Expense Ratio1.040.042,600%
Fund Existence8 years27 years-
Gain YTD10.9847.821140%
Front LoadN/AN/A-
Min. Initial Investment2500000500000050%
Min. Initial Investment IRAN/AN/A-
Net Assets136M196B0%
Annual Yield % from dividends2.802.11133%
Returns for 1 year9.866.80145%
Returns for 3 years23.6936.0866%
Returns for 5 years8.2170.0912%
Returns for 10 yearsN/A137.36-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPCX12.97N/A
N/A
Saratoga Health & Biotechnology C
HHDVX36.53N/A
N/A
Hamlin High Dividend Equity Inv
GCINX15.17N/A
N/A
Green Century MSCI Intl Indx Indvl Inv
ARYCX25.13N/A
N/A
American Century Real Estate C
HCAFX45.20N/A
N/A
Hartford Capital Appreciation F